The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study.
 
Shiraj Sen
No Relationships to Disclose
 
Muhammad Rizwan-ul-Haq Khawaja
No Relationships to Disclose
 
Soumen Khatua
No Relationships to Disclose
 
Daniel D. Karp
No Relationships to Disclose
 
Filip Janku
Consulting or Advisory Role - Deciphera; Trovagene
Research Funding - Biocartis; BioMed Valley Discoveries; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
David S. Hong
Research Funding - AstraZeneca (Inst); Eisai (Inst); Genentech (Inst); miRNA Therapeutics (Inst); novartis (Inst); Pfizer (Inst)
 
Javier Munoz
No Relationships to Disclose
 
Apostolia Maria Tsimberidou
Research Funding - Baxter (Inst); EMD Serono (Inst); Foundation Medicine (Inst); ONYX (Inst)
 
Wafik Tharwat Zaky
No Relationships to Disclose
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Vivek Subbiah
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche/Genentech (Inst)